IL-6 and TNF-α levels rise in both blood and CSF in RRMS and SP/PPMS, with serum TNF-α correlating with disease progression in PPMS, and IL-6 levels correlating with the disease duration [54,80]. This evidence concerns the gene TNF and primary progressive multiple sclerosis.